Search results
David Duchovny admits to trouble ‘reattaching’ to daughter after nearly losing her to 'horrifying' ...
Fox News via Yahoo News· 3 days ago"When my daughter West was 9 months old, she got RSV, which kind of was in the news again a couple...
Adult RSV Shots Given to More Than 30 Babies by Mistake
MedPage Today· 3 days agoNearly three dozen babies and young children have received respiratory syncytial virus (RSV)...
FDA Delays Decision on Moderna RSV Shot by 3 Weeks
Barrons.com· 2 days agoThe agency was originally scheduled to announce its call on Sunday. The company said it hadn’t flagged any issues with the drug’s safety, efficacy, or...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters· 2 days ago, opens new tab respiratory syncytial virus (RSV) vaccine due to "administrative constraints" and...
Moderna: FDA Extends RSV Vaccine Review, But No Issues Flagged
Morningstar· 2 days agoModerna on Friday said the Food and Drug Administration won't meet its May 12 target action date for a decision on the company's proposed vaccine for respiratory syncytial virus, or
Moderna says FDA delayed RSV vaccine approval to end of May
CNBC· 2 days agoThe FDA was expected to make a decision on the RSV shot on Sunday. The agency has not informed...
FDA delays decision on Moderna's RSV shot until the end of May
FierceBiotech· 2 days agoModerna will have to consider that after receiving word that the FDA will not meet a May 12 decision...
H.C. Wainwright drops Enanta Pharmaceuticals shares target on RSV program progress By Investing.com
Investing.com· 4 days agoThis move comes after Enanta Pharmaceuticals provided an update on its ongoing clinical trials for...
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
Investor's Business Daily· 2 days agoModerna stock toppled Friday after the Food and Drug Administration delayed an approval decision on...
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2024 Earnings Call Transcript May 6, 2024 Enanta...